Inopharma

Daegu, South Korea · Founded 2023 · Privately Held (backing)

Developer of hemostatic medical devices designed to control bleeding in emergency and clinical environments. Inopharma is based in Daegu, South Korea and was founded in 2023. Its last reported valuation was $4.2 million in Apr 2026. It has raised $10,000.

Last reported valuation
$4.2M
Oct 2026
Priced at
—
Total raised
$10K
Last round
—

Who backs Inopharma?

9 investors
InvestorType
Tech Incubator Program for StartupOther
Center for Creative Economy and InnovationOther
A-One AC—
Find Us—
InfoBank—
MobyDick Ventures—
Sooki Park—
Wonhyo Kim—
iAccel (Seongnam-si)—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Inopharma investors

9 investors are on record for Inopharma, including Tech Incubator Program for Startup, Center for Creative Economy and Innovation, A-One AC and Find Us.

Free account
More of Inopharma with a free account
  • ·Watch Inopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Inopharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View